717 related articles for article (PubMed ID: 16520435)
21. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
[TBL] [Abstract][Full Text] [Related]
22. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.
Litz BT; Salters-Pedneault K; Steenkamp MM; Hermos JA; Bryant RA; Otto MW; Hofmann SG
J Psychiatr Res; 2012 Sep; 46(9):1184-90. PubMed ID: 22694905
[TBL] [Abstract][Full Text] [Related]
23. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
Smits JAJ; Pollack MH; Rosenfield D; Otto MW; Dowd S; Carpenter J; Dutcher CD; Lewis EM; Witcraft SM; Papini S; Curtiss J; Andrews L; Kind S; Conroy K; Hofmann SG
JAMA Netw Open; 2020 Jun; 3(6):e206777. PubMed ID: 32496566
[TBL] [Abstract][Full Text] [Related]
24. Treating university students with social phobia and public speaking fears: Internet delivered self-help with or without live group exposure sessions.
Tillfors M; Carlbring P; Furmark T; Lewenhaupt S; Spak M; Eriksson A; Westling BE; Andersson G
Depress Anxiety; 2008; 25(8):708-17. PubMed ID: 18729147
[TBL] [Abstract][Full Text] [Related]
25. D-cycloserine enhances generalization of fear extinction in children.
Byrne SP; Rapee RM; Richardson R; Malhi GS; Jones M; Hudson JL
Depress Anxiety; 2015 Jun; 32(6):408-14. PubMed ID: 25775435
[TBL] [Abstract][Full Text] [Related]
26. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
[TBL] [Abstract][Full Text] [Related]
27. Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine.
Yurgelun-Todd DA; Coyle JT; Gruber SA; Renshaw PF; Silveri MM; Amico E; Cohen B; Goff DC
Psychiatry Res; 2005 Jan; 138(1):23-31. PubMed ID: 15708298
[TBL] [Abstract][Full Text] [Related]
28. Cognitive behavioral therapy for public-speaking anxiety using virtual reality for exposure.
Anderson PL; Zimand E; Hodges LF; Rothbaum BO
Depress Anxiety; 2005; 22(3):156-8. PubMed ID: 16231290
[TBL] [Abstract][Full Text] [Related]
29. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
[TBL] [Abstract][Full Text] [Related]
30. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
31. Effect of quetiapine vs. placebo on response to two virtual public speaking exposures in individuals with social phobia.
Donahue CB; Kushner MG; Thuras PD; Murphy TG; Van Demark JB; Adson DE
J Anxiety Disord; 2009 Apr; 23(3):362-8. PubMed ID: 19157776
[TBL] [Abstract][Full Text] [Related]
32. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
Hofmann SG; Smits JA; Rosenfield D; Simon N; Otto MW; Meuret AE; Marques L; Fang A; Tart C; Pollack MH
Am J Psychiatry; 2013 Jul; 170(7):751-8. PubMed ID: 23599046
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
34. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
[TBL] [Abstract][Full Text] [Related]
35. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
[TBL] [Abstract][Full Text] [Related]
36. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
[TBL] [Abstract][Full Text] [Related]
37. A prospective examination of predictors of post-event processing following videotaped exposures in group cognitive behavioural therapy for individuals with social phobia.
Laposa JM; Rector NA
J Anxiety Disord; 2011 May; 25(4):568-73. PubMed ID: 21330099
[TBL] [Abstract][Full Text] [Related]
38. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
Smits JA; Rosenfield D; Davis ML; Julian K; Handelsman PR; Otto MW; Tuerk P; Shiekh M; Rosenfield B; Hofmann SG; Powers MB
Biol Psychiatry; 2014 Jun; 75(11):840-6. PubMed ID: 24237691
[TBL] [Abstract][Full Text] [Related]
39. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.
Heresco-Levy U; Javitt DC; Gelfin Y; Gorelik E; Bar M; Blanaru M; Kremer I
J Affect Disord; 2006 Jul; 93(1-3):239-43. PubMed ID: 16677714
[TBL] [Abstract][Full Text] [Related]
40. Is virtual reality effective to motivate and raise interest in phobic children toward therapy? A clinical trial study of in vivo with in virtuo versus in vivo only treatment exposure.
St-Jacques J; Bouchard S; Bélanger C
J Clin Psychiatry; 2010 Jul; 71(7):924-31. PubMed ID: 20441721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
